Clinical Trial Update: Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the combination of EH-301 and N-acetylcysteine with riluzole in amyotrophic lateral sclerosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• EH-301
• N-acetylcysteine (N-acetylcysteine)
• Riluzole (riluzole)

Snippet

Sponsor: Biogipuzkoa Health Research Institute | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: RECRUITING